Harro Höfliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market
leon-nanodrugs GmbH and Harro Höfliger, announce today their collaboration on a manufacturing device to encapsulate mRNAs or active pharmaceutical ingredients (APIs) into lipid nanoparticles (LNPs). NANOus is a flexible small-to-high-volume manufacturing device designed for aseptic GMP-compliant nanoencapsulation of APIs, based on LEON’s proprietary NANOnow technology.
The two companies are in the process of assembling the market-ready device, which will enable rapid and cost-efficient, seamless scale-up for production of LNP-encapsulated therapeutics. NANOus can enable continuous manufacturing of several million vaccine doses per day. The collaboration builds on Harro Höfliger’s longstanding experience and engineering capabilities in order to meet the needs of the manufacturing pharmaceutical sector, while LEON provides access to its core technology platform NANOnow.
Find out more:
PR_LEON and Harro Höfliger cooperation_EN
PR_LEON und Harro Höfliger_Kooperation_DE
About LEON
LEON offers leading Technology for the encapsulation of nucleic acids, biomolecules, and other APIs.
Highly flexible GMP manufacturing solutions for your genetic payloads and other molecules.
LEON utilises its’ proprietary nano technology platform for the continuous manufacturing of SMART nanoparticles (ranging from surface stablilised polymeric through to lipid nanoparticles (LNP’s) and liposomes). For general information and enquiries please email info@leon-nanodrugs.com